10x Genomics, Inc. (TXG): Cash & Equivalents
$344.07M
As of 2024-12-31
-16.3%
3-year compound annual growth
-4.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $344.07M | -4.2% | 2025-02-13, Balance as of period end |
| 2023-12-31 | $359.28M | +63.5% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $219.75M | -62.6% | 2025-02-13, Balance as of period end |
| 2021-12-31 | $587.45M | -11.5% | 2024-02-15, Balance as of period end |
| 2020-12-31 | $663.60M | +56.4% | 2023-02-16, Balance as of period end |
| 2019-12-31 | $424.17M | +551.8% | 2022-02-18, Balance as of period end |
| 2018-12-31 | $65.08M | +36.0% | 2021-02-26, Balance as of period end |
| 2017-12-31 | $47.86M | n/a | 2020-02-27, Balance as of period end |